<DOC>
	<DOCNO>NCT00189059</DOCNO>
	<brief_summary>The acute subchronic effect amitriptyline compare placebo double-blind crossover randomize study drive ability driving-related skill chronic neuropathic pain patients.It hypothesize nocturnally administer 25 mg amitriptyline might affect drive performance negatively acute , subchronic treatment .</brief_summary>
	<brief_title>Effects Amitriptyline Treatment Pain Driving Performance Cognition .</brief_title>
	<detailed_description>The present study design determine effect nocturnally administer 25 mg amitriptyline , compare placebo , single ( Day 1 , acute effect ) repeat ( Day 15 , subchronic effect ) administration drive performance neuropathic pain patient . In addition on-the-road driving test , laboratory test measure driving-related skill administer . Moreover , effect amitriptlyine attentional capacity task test use Event-Related Potentials ( ERPs ) . It hypothesize nocturnally administer 25 mg amitriptyline might affect drive performance negatively acute , subchronic treatment .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>age , amitriptyline responder , adequately treated amitriptyline study dose study participation , pain intensity score ( VAS ) least 4 cm 10 cm scale , drive licence , drive experience , speak fluently Dutch , normal vision , righthanded psychological physical disorder pain ( relate ) , psychotropic medication use , excessive drinking smoking , alcohol drug dependence , illigal drug use</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>neuropathic pain</keyword>
	<keyword>erp</keyword>
	<keyword>drive</keyword>
	<keyword>attention</keyword>
	<keyword>amitriptyline</keyword>
</DOC>